-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) includes three subtypes, Crohn's disease (CD), ulcerative colitis (UC), and unclassified IBD (IBDu), affecting more than 2 million Europeans and 1.
5 million North Americans
.
Depression and anxiety have been shown to be the triggers for the recurrence of clinical diseases
.
Inflammatory bowel disease (IBD) includes three subtypes, Crohn's disease (CD), ulcerative colitis (UC), and unclassified IBD (IBDu), affecting more than 2 million Europeans and 1.
Researchers tested the relationship between personality tests, depressive symptoms (depression score ≥11 on the Hospital Anxiety and Depression Scale) and recurrent IBD in an IBD cohort of patients at a Swiss medical center
.
Of the 2275 patients (1005 ulcerative colitis, 1270 Crohn's disease), 672 (29.
5%) had type D personality
.
Type D personality is an important risk factor for long-term IBD recurrence (adjusted hazard ratio, aHR: 1.
60, P=0.
Figure: The impact of type D personality on disease recurrence
This study confirms that the prevalence of type D personality in IBD patients is comparable to the prevalence in the general population
.
However, type D personality is closely related to depressive symptoms, and is independently related to the recurrence of IBD
.
This study confirms that the prevalence of type D personality in IBD patients is comparable to the prevalence in the general population
Original source:
Sebastian Bruno Ulrich Jordi.
Et al.
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
Leave a message here